• Explore /
  • Poster
  • / Pembrolizumab (pembro) plus docetaxel and prednisone in patients (pts) with abiraterone acetate (abi) or enzalutamide (enza)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort B efficacy, safety and, biomarker results.

Pembrolizumab (pembro) plus docetaxel and prednisone in patients (pts) with abiraterone acetate (abi) or enzalutamide (enza)-pretreated metastatic castration-resistant prostate cancer (mCRPC): KEYNOTE-365 cohort B efficacy, safety and, biomarker results.

Abstract Video & Slides Poster

Authors

null

Srikala S. Sridhar

Princess Margaret Cancer Centre, Toronto, ON, Canada

Srikala S. Sridhar , Michael Paul Kolinsky , Gwenaelle Gravis , Loic Mourey , Jose Maria M. Piulats Rodriguez , Emanuela Romano , William R. Berry , Howard Gurney , Margitta Retz , Leonard Joseph Appleman , Martin Boegemann , Johann S. De Bono , Anthony M. Joshua , Urban Emmenegger , Henry Jacob Conter , Brigitte Laguerre , Haiyan Wu , Ping Qiu , Charles Schloss , Evan Y. Yu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer - Advanced Disease

Clinical Trial Registration Number

NCT02861573

Citation

J Clin Oncol 38: 2020 (suppl; abstr 5550)

DOI

10.1200/JCO.2020.38.15_suppl.5550

Abstract #

5550

Poster Bd #

131

Abstract Disclosures

Similar Posters

First Author: Henry Jacob Conter

First Author: Evan Y. Yu

First Author: Peter C.C. Fong

First Author: Neeraj Agarwal